Green tea (Camellia sinensis) attenuates nephropathy by downregulating Nox4 NADPH oxidase in diabetic spontaneously hypertensive rats

Journal of Nutrition

Volumn 139, Issue 1, 2009, Pages 96-100

  Ribaldo, Perola D B ^a   Souza, Denise S ^a   Biswas, Subrata K ^a   Block, Karen ^b   De Faria, Jacqueline M Lopes ^a   De Faria, José B Lopes ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; COLLAGEN TYPE 4; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SUPEROXIDE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; GLUCOSE BLOOD LEVEL; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TEA; WEIGHT CHANGE;

ANIMALS; BIOLOGICAL MARKERS; CAMELLIA SINENSIS; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; KIDNEY DISEASES; NADPH OXIDASE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; RATS, INBRED SHR; SUPEROXIDES;

CAMELLIA SINENSIS; RATTUS;

EID: 58649097031     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.095018     Document Type: Article

References (32)

1. Hypertension in Diabetes Study (HDS). I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993;11:309-17.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-53.
3. The Diabetes Control and Complications (DCCT) Trial Research Group. Effect of intensive therapy on the development of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int. 1995;47:1703-20.
4. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Study Group. BMJ. 1998; 317:703-13.
5. Parving HH, Smidt UM, Hommel E, Mathiesen ER, Rossing P, Nielsen F, Gall MA. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis. 1993;22:188-95.
6. Cooper ME, Allen TJ, O'Brien RC, Macmillan PA, Clarke B, Jerums G, Doyle AE. Effect of genetic hypertension on diabetic nephropathy in the rat: functional and structural characteristics. J Hypertens. 1988;6: 1009-16.
7. Amazonas RB, Lopes de Faria JB. Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension and experimental diabetes mellitus. Life Sci. 2006;79:1235-43.
8. Giunti S, Barit D, Cooper ME. Mechanism of diabetic nephropathy: role of hypertension. Hypertension. 2006;48:519-26.
9. Prabhakar S. Starnes J, Shi S, Lonis B, Tran R. Diabetic nephropathy is associated with oxidative stress and decreased renal oxide production. J Am Soc Nephrol. 2007;18:2945-52.
10. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615-25.
11. Vaziri ND, Rodriguez-Iturbe B. Mechanism of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol. 2006;2:582-93.
12. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemia damage. Nature. 2000;404:787-90.
13. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R, Channon KM. Mechanism of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation. 2002;105:1656-62.
14. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension. 2002;39:269-74.
15. Biswas SK, Lopes de Faria JB, Which comes first: renal inflammation or oxidative stress in spontaneously hypertensive rats? Free Radic Res. 2007;41:216-24.
16. Cui XL, Douglas JG. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci USA. 1997;94:3771-6.
17. Jones SA, Hancock JT, Jones OT, Neubauer A, Topley N. The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox. J Am Soc Nephrol. 1995;5:1483-91.
18. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005;67:1890-8.
19. Biswas SK, Peixoto EB, Souza DS, Lopes de Faria JB. Hypertension increases pro-oxidant and decreases antioxidant defense in the kidney in early diabetes. Am J Nephrol. 2008;28:133-42.
20. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE. Nox4 NAD(P)H oxidase mediates hypertrophy and fibro-nectin expression in the diabetic kidney. J Biol Chem. 2005;280:39616-26.
21. Asaba K, Tojo A, Onozato ML, Goto A, Fujita T. Double-edged action of SOD mimetic in diabetic nephropathy. J Cardiovasc Pharmacol. 2007;49:13-9.
22. 2+ superoxide dismutase protects against early diabetic glo-merular injury in transgenic mice. Diabetes. 2001;50:2114-25.
23. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43:89-143.
24. Potenza MA, Marasciulo FL, Tarquinio M, Tiravanti E, Colantuono G, Federici A, Kim JA, Quon MJ, Montagnani M. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab. 2007;292:E1378-87.
25. Renno WM, Abdeen S, Alkhalaf M, Asfar S. Effect of green tea on tubules of diabetic rats. Br J Nutr. 2008;100:652-9.
26. Mustata GT, Rosca M, Biemel KM, Reihl O, Smith MA, Viswanathan A, Strauch C, Du Y, Tang J, et al. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats. Diabetes. 2005;54:517-26.
27. Bradford MM. A rapid and sensitive method for the quantitation of microgram of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:248-54.
28. Matthew JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300:230-5.
29. Yamabe N, Yokozawa T, Oya T, Kim M. Therapeutic potential of (-)- epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther. 2006;319:228-36.
30. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA. 2000;97:8010-4.
31. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H. Increased expression of NADPH oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment. Diabetologia. 2003;46:1428-37.
32. Fujii M, Inoguchi T, Maeda Y, Sasaki S, Sawada F, Saito R, Kobayashi K, Sumimoto H, Takayanagi R. Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Kidney Int. 2007;72:473-80.